Navigation Links
A Likely Use For Estrogen Therapy

A new study shows that estrogen therapy does not decrease, but may increase, the risk for dementia in postmenopausal women, say researchers //.Previous studies have reported an association between postmenopausal estrogen use and lower risk of dementia.

A placebo-controlled trial of estrogen or estrogen plus progestin in women aged 65 to 79 years looked at associated risk for dementia. In the estrogen-only trial, researchers found 47 participants were diagnosed with probable dementia, of whom 28 were assigned to receive estrogen. During follow-up, the incidence of dementia was 49-percent higher among women receiving estrogen only compared to those receiving placebo. Similar results were found in the estrogen-plus-progestin trial. Researchers say these findings showed only slightly lower-than-average cognitive function, but when data from the two trials were pooled, the overall risk for probable dementia was significantly increased by 76 percent.

Thus researchers conclude that the use of hormone therapy to prevent dementia or [mild cognitive impairment] in women 65 years of age or older is not recommended and they say that more research is required to confirm their findings.

Page: 1

Related medicine news :

1. Likely reason which makes analgesics work against Alzheimers
2. Homeless More Likely to Die Early
3. Blood Transfusion A Likely Cause For A Rare And Fatal Brain Disorder
4. Sleep Disorder,The Likely Cause Of Most Road Accidents
5. Premature Babies More Likely If Women Have Higher Protein Albumin In Urine
6. Women Less Likely To Conceive Post-Caesarean
7. Obesity More Likely to Cause Disability than Death in Elderly
8. A Likely Breakthrough For Prostate Cancer Patients
9. Bird Flu Likely To Reduce World Energy Demand
10. Men More Likely To Lose Teeth To Periodontal Disease
11. Women Who Smoke Are More Likely To Get Breast Cancer
Post Your Comments:

(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: